Conjoint committee to release report

As criticism over commercial support for CME continues, a national recommendation on the funding issue is imminent from the Conjoint Committee on CME (CCCME).

Formed in 2009 at the behest of the Institute of Medicine, which called for a national dialogue to assure a CME funding system free of commerical influence. The CCCME is unlikely to declare commercial support problematic, said Dr. Norman Kahn Jr., convener of the group.

Kahn told MM&M that the data are “incontrovertible” that direct financial payments to faculty lead to influence, but a commercially supported CME activity whose faculty have no such ties most likely does not lead to bias. “[W]ithin the context of the firewalls created by the ACCME's Standards for Commercial Support, it's the opinion of the profession that if you follow this framework, you can eliminate influence from commercial support,” he said.

Specifics on how to manage conflicts will find their way into the committee's report, due out in January. A March 17 summit is planned for Chicago.
You must be a registered member of MMM to post a comment.

Next Article in Features

Content marketing is not advertising in the old sense. In its use of social media, content marketing challenges consumers while relying on their input. It is proactive and responsive to their concerns, needs and energy. Content marketing has become the new voice of marketing. Learn what you need to know and how pharma marketers can adapt to this innovative venture into social media by clicking here for access.

Email Newsletters